Q2 outlook disappoints market, but Elekta is only for the patient ones
28/08/25 -"While Q1 profitability exceeded expectations, investors were disappointed by the weak Q2 outlook due to expected underperformance in the US and China, alongside FX headwinds and tariff impacts. ..."
Pages
61
Language
English
Published on
28/08/25
You may also be interested by these reports :
29/08/25
Despite being a dominant player in the ophthalmology space, Alcon has been reeling under the pressure of slower than expected market growth this ...
28/08/25
While Q1 profitability exceeded expectations, investors were disappointed by the weak Q2 outlook due to expected underperformance in the US and ...
21/08/25
GN’s Q2 performance surpassed market expectations. Although top-line growth was constrained by an uncertain macroeconomic environment, profitability ...
20/08/25
The Q2 results fell short of expectations and, consequently, the management downgraded its guidance for the second time this year. A subdued market ...